New data boosts AstraZeneca COVID-19 vaccine in US
The trials in the US, Chile and Peru showed the vaccine was 79 per cent effective at preventing symptomatic COVID-19
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Researchers at IISER Bhopal, Nebraska University identify drug that can be repurposed to treat…
Rapamycin used to prevent organ rejection after transplants and in cancer treatment was found to have anti-ageing effect and…
Glenmark, Bausch Health partner to commercialise RYALTRIS nasal spray in Canada
RYALTRIS is currently under review by Health Canada with a proposed indication for the treatment of seasonal allergic rhinitis in…
South Africa sells COVID-19 vaccines procured from AstraZeneca to other AU member states
The country had paused AstraZeneca vaccinations last month because of a small trial showing the shot offered minimal protection…
92 per cent decrease in UK COVID-19 cases since Jan: GlobalData
The ending of the national lockdown and the reopening of schools and non-essential industries in April will be a true test of the…
My role is to act like a catalyst
Nikhil Chopra recently took over as CEO and Whole-time Director of JB Chemicals & Pharmaceuticals. In a free-wheeling…
L M College of Pharmacy organises international e-Conference on Biologics in Healthcare
A plethora of speakers from biotech companies and universities in the US and India shared their expert knowledge and experience on…
8-10 months protection possible with COVID-19 vaccine: AIIMS director
He said the biggest reason for the surge in cases is that people feel the pandemic is over and they are not following…
Premas Biotech, Oramed announce single-dose oral COVID-19 vaccine candidate
Clinical trials expected to commence Q2 2021
NPPA increases WPI by 0.53638 per cent, industry unhappy
Stakeholders request a one-time increase of 20 per cent over and above WPI